消化威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 消化威廉亚洲博彩公司

2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理

2021-05-10 美国结肠和直肠外科医师学会 Dis Colon Rectum. 2021 Jun 1;64(6):650-668.

艰难梭菌感染

2021年，美国结肠和直肠外科医师学会(ASCRS)发布了艰难梭菌感染的管理威廉亚洲博彩公司 。威廉亚洲博彩公司 主要针对艰难梭菌感染的管理提供指导建议，内容涉及评估、药物治疗、手术治疗以及复发或难治性艰难梭菌感染的管理。

中文标题：

2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理

英文标题：

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection

发布机构：

美国结肠和直肠外科医师学会

发布日期：

2021-05-10

简要介绍：

2021年，美国结肠和直肠外科医师学会(ASCRS)发布了艰难梭菌感染的管理威廉亚洲博彩公司 。威廉亚洲博彩公司 主要针对艰难梭菌感染的管理提供指导建议，内容涉及评估、药物治疗、手术治疗以及复发或难治性艰难梭菌感染的管理。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0062c1c00210597e, title=2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理, enTitle=The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection, guiderFrom=Dis Colon Rectum. 2021 Jun 1;64(6):650-668., authorId=0, author=, summary=2021年，美国结肠和直肠外科医师学会(ASCRS)发布了艰难梭菌感染的管理威廉亚洲博彩公司 。威廉亚洲博彩公司 主要针对艰难梭菌感染的管理提供指导建议，内容涉及评估、药物治疗、手术治疗以及复发或难治性艰难梭菌感染的管理。, cover=https://img.medsci.cn/2021525/1621876416110_2020535.jpg, journalId=0, articlesId=null, associationId=463, associationName=美国结肠和直肠外科医师学会, associationIntro=美国结肠直肠癌的外科医生(ASCRS)学会是第一个对结肠直肠癌外科医生和其他外科的学会，她致力于推进科学与实践,缓解患者的治疗疾病和紊乱影响结肠、直肠和肛门疾病以及功能紊乱对患者的影响。已经有超过1000家学会的2600多个成员都认可了美国董事会结肠直肠癌的外科手术。, copyright=0, guiderPublishedTime=Mon May 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年，美国结肠和直肠外科医师学会(ASCRS)发布了艰难梭菌感染的管理威廉亚洲博彩公司 。威廉亚洲博彩公司 主要针对艰难梭菌感染的管理提供指导建议，内容涉及评估、药物治疗、手术治疗以及复发或难治性艰难梭菌感染的管理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=11318, tagName=艰难梭菌感染)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11318, guiderKeyword=艰难梭菌感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10049, appHits=136, showAppHits=0, pcHits=519, showPcHits=9913, likes=2, shares=28, comments=7, approvalStatus=1, publishedTime=Tue May 25 01:13:52 CST 2021, publishedTimeString=2021-05-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 25 01:13:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 03:24:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理.pdf)])
2021 ASCRS临床实践威廉亚洲博彩公司 ：艰难梭菌感染的管理.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082373, encodeId=7fea10823e32b, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:44:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009098, encodeId=70481009098ad, content=合理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:55:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973971, encodeId=48249e39718e, content=积极防控，科学合理用药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Wed Jun 16 07:37:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968387, encodeId=a13f96838e75, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66975502111, createdName=扬帆破浪, createdTime=Tue May 25 16:03:35 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968310, encodeId=7a639683103b, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Tue May 25 07:32:54 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082373, encodeId=7fea10823e32b, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:44:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009098, encodeId=70481009098ad, content=合理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:55:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973971, encodeId=48249e39718e, content=积极防控，科学合理用药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Wed Jun 16 07:37:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968387, encodeId=a13f96838e75, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66975502111, createdName=扬帆破浪, createdTime=Tue May 25 16:03:35 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968310, encodeId=7a639683103b, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Tue May 25 07:32:54 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-08-18 于四方

    合理

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082373, encodeId=7fea10823e32b, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:44:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009098, encodeId=70481009098ad, content=合理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:55:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973971, encodeId=48249e39718e, content=积极防控，科学合理用药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Wed Jun 16 07:37:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968387, encodeId=a13f96838e75, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66975502111, createdName=扬帆破浪, createdTime=Tue May 25 16:03:35 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968310, encodeId=7a639683103b, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Tue May 25 07:32:54 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-06-16 smart Ren

    积极防控，科学合理用药

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082373, encodeId=7fea10823e32b, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:44:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009098, encodeId=70481009098ad, content=合理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:55:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973971, encodeId=48249e39718e, content=积极防控，科学合理用药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Wed Jun 16 07:37:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968387, encodeId=a13f96838e75, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66975502111, createdName=扬帆破浪, createdTime=Tue May 25 16:03:35 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968310, encodeId=7a639683103b, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Tue May 25 07:32:54 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-05-25 扬帆破浪

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082373, encodeId=7fea10823e32b, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:44:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009098, encodeId=70481009098ad, content=合理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:55:27 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973971, encodeId=48249e39718e, content=积极防控，科学合理用药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Wed Jun 16 07:37:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968387, encodeId=a13f96838e75, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66975502111, createdName=扬帆破浪, createdTime=Tue May 25 16:03:35 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968310, encodeId=7a639683103b, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Tue May 25 07:32:54 CST 2021, time=2021-05-25, status=1, ipAttribution=)]
    2021-05-25 smart Ren

    认真学习

    0

相关威廉亚洲博彩公司

2020 台湾艰难梭菌感染治疗威廉亚洲博彩公司 建议

中国感染病相关专家组（统称） · 2020-02-14

2020 SEQ/SEMI/SEDAR临床实践威廉亚洲博彩公司 ：艰难梭菌感染的诊断和治疗建议

西班牙化疗学会(SEQ,Spanish Society of Chemotherapy) · 2020-02-20

2020 专家声明：重症患者艰难梭菌感染

国外感染病相关专家组（统称） · 2020-01-14

2019 WSES威廉亚洲博彩公司 ：手术患者艰难梭菌感染的管理（更新）

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2019-02-28

2019 ASID/ACIPC立场声明：医疗机构内艰难梭菌感染患者的感染控制

澳大利亚传染病协会(ASID,Australasian Society for Infectious Diseases) · 2019-01-30

2018 AMMI实践威廉亚洲博彩公司 ：艰难梭菌感染的治疗

加拿大医学微生物与感染病协会(AMMI,Association of Medical Microbiology and Infectious Disease Canada) · 2018-06-29

拓展阅读

2017 IDSA/SHEA临床实践威廉亚洲博彩公司 ：成人和儿童艰难梭菌感染的管理（更新版）

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2018-02-15

2018 ESGCD威廉亚洲博彩公司 ：急诊医疗中艰难梭菌感染的预防

欧洲艰难梭菌研究小组(ESGCD,European Study Group for C. difficile) · 2018-03-02

2018 BSG/HIS威廉亚洲博彩公司 ：粪菌移植治疗复发性难治性艰难梭菌感染以及其他潜在并发症

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2018-08-25

2018 AMMI实践威廉亚洲博彩公司 ：艰难梭菌感染的治疗

加拿大医学微生物与感染病协会(AMMI,Association of Medical Microbiology and Infectious Disease Canada) · 2018-06-29

2019 ASID/ACIPC立场声明：医疗机构内艰难梭菌感染患者的感染控制

澳大利亚传染病协会(ASID,Australasian Society for Infectious Diseases) · 2019-01-30

2019 WSES威廉亚洲博彩公司 ：手术患者艰难梭菌感染的管理（更新）

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2019-02-28